Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is highly rated in 25 conditions, according to our data. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is highly rated in 21 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is highly rated in 19 conditions, according to our data. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is highly rated in 19 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.

Lee Akst, M.D., specializes in treating the larynx (voicebox), in particular the treatment of voice and swallowing disorders. He is a leading laryngologist in office-based procedures such as vocal fold injection augmentation, pulsed KTP laser treatment, and laryngeal botox injection. In the operating room, Dr. Akst specializes in phonosurgery for the treatment of vocal cord disease, with emphasis on voice restoration and improvement. A strong focus of his practice involves the use of pulsed angiolytic lasers, which allow for subspecialized care of laryngeal papillomas, laryngeal dysplasia, and early vocal cord cancers while preserving the quality and strength of the voice. Dr. Akst is a national leader in the field of laryngology and serves in leadership roles for the American Laryngological Association, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology-Head and Neck Surgery. He lectures extensively on the treatment of laryngeal disease, teaching other physicians how to care for patients with voice and swallowing concerns. His research interests include the development of robotic laryngeal surgery, the study of voice and swallowing complaints in the elderly, and the advancement of pulsed lasers for the treatment of laryngeal diseases with a focus on leukoplakia. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Akst is highly rated in 17 conditions, according to our data. His top areas of expertise are Spasmodic Dysphonia, Laryngitis, Perichondritis, Endoscopy, and Laryngectomy.

Neurotologist John Carey specializes in the health and diseases of the inner ear that affect both balance and hearing mechanisms. He is a national expert in superior canal dehiscence syndrome, Menière’s disease, vestibular migraine, acoustic neuromas and other causes of vertigo, and serves as chief of the Division of Otology, Neurotology and Skull Base Surgery in the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Carey earned a medical degree from Washington University School of Medicine and completed two years of training in general surgery at Virginia Mason Medical Center. This was followed by residency training in otolaryngology–head and neck surgery at University of Washington Medical Center and fellowship training in neurotology at the Johns Hopkins University School of Medicine. His research interests include superior canal dehiscence syndrome, Menière’s disease, vestibular implants, and the mechanisms of vestibular migraine. He has a particular interest in superior canal dehiscence syndrome, and, with Lloyd Minor, department director from 2003 to 2009, he helped develop the operation used to repair the superior canal. Dr. Carey has been funded by the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health. He has authored or co-authored over 150 peer-reviewed publications, 10 book chapters, and 11 reviews. Dr. Carey is highly rated in 17 conditions, according to our data. His top areas of expertise are Vertigo, Meniere Disease, Acoustic Neuroma, Mastoidectomy, and Endoscopy.

Head and neck surgeon David Eisele specializes in surgery for malignant and benign tumors of the head and neck, with a focus on salivary gland neoplasms and disorders of the salivary glands that can be treated surgically. He is an expert in minimally invasive surgical approaches, including sialendoscopy. Salivary gland neoplasms and disorders are also the focus of Dr. Eisele’s research. He has published more than 300 research papers and edited multiple books related to head and neck surgery. Dr. Eisele earned a medical degree from Cornell University Medical College and completed residency training in general surgery and in otolaryngology–head and neck surgery at the University of Washington. From 2012 to 2025, he served as director of the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Eisele is highly rated in 16 conditions, according to our data. His top areas of expertise are Salivary Duct Stones, Salivary Gland Tumors, Throat Cancer, Laryngectomy, and Gastrostomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is highly rated in 14 conditions, according to our data. Her top areas of expertise are Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Laryngectomy, and Gastrostomy.

David Newman-Toker, M.D., Ph.D., is an internationally recognized leader in neuro-otology, acute stroke diagnosis, and diagnostic errors research. He completed his undergraduate studies at Yale University, his medical degree at University of Pennsylvania, his residency training and neuro-ophthalmology fellowship at Harvard University, his neuro-otology fellowship at Johns Hopkins University School of Medicine, and his doctoral degree in clinical research methods at the Johns Hopkins Bloomberg School of Public Health. He has served as a full-time faculty member at the Johns Hopkins University School of Medicine since 2002. He is the David Robinson Professor of Vestibular Neurology and also holds appointments in Otolaryngology, Ophthalmology, Emergency Medicine, Acute Care Nursing, Health Sciences Informatics, Epidemiology, and Health Policy & Management at Johns Hopkins. Dr. Newman-Toker is a bedside-to-populations translational researcher, with a focus on eliminating diagnostic errors and achieving diagnostic excellence. He is a leader in the national and international movements to eliminate patient harms from diagnostic error. Dr. Newman-Toker’s clinical focus is on diagnosis of acute disorders affecting the brainstem and cranial nerves, particularly stroke. He is recognized for his research in novel eye-movement-based bedside methods for diagnosing stroke in patients with acute dizziness and vertigo in the emergency department and, in 2024, won the international Bárány Society’s Hallpike-Nylén Prize for clinical research achievement. Dr. Newman-Toker serves as director of the Division of Neuro-Visual & Vestibular Disorders in the Department of Neurology. He also directs the Armstrong Institute Center for Diagnostic Excellence, whose mission is to catalyze efforts to improve diagnostic performance, develop the science of diagnostic safety, and enhance diagnostic research. He has been the principal investigator on numerous National Institutes of Health, Agency for Healthcare Research and Quality (AHRQ), and foundation grants. He has published over 165 journal articles and given more than 300 invited lectures. He has served as an expert consultant on diagnostic safety and quality to AHRQ, the National Quality Forum, and the National Academy of Medicine. He has testified before Congress on the use of artificial intelligence for medical diagnosis. He was president of the Society to Improve Diagnosis in Medicine from 2018-2020. Dr. Newman is highly rated in 6 conditions, according to our data. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Stroke, and Brown Syndrome.

Vassiliki Saloura is an Otolaryngologist and an Oncologist in Baltimore, Maryland. Dr. Saloura is highly rated in 3 conditions, according to our data. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Wolf-Hirschhorn Syndrome, Glioma, and Tongue Cancer.

Dr. Nieman is an associate professor in the division of otology, neurotology and skull base surgery in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery. Her clinical practice is dedicated to the medical and surgical management of hearing loss and Eustachian tube disorders. Dr. Nieman's research is directed at understanding and addressing hearing health disparities among older adults, particularly among vulnerable populations. Her work focuses on the development and implementation of innovative, community-delivered approached to affordable, accessible hearing care. Dr. Nieman is highly rated in 2 conditions, according to our data. Her top areas of expertise are Hearing Loss, Infant Hearing Loss, Jones Syndrome, DFNB1, and Myringotomy.

David Eisenman is an Otolaryngologist in Baltimore, Maryland. Dr. Eisenman is highly rated in 20 conditions, according to our data. His top areas of expertise are Tinnitus, Acoustic Neuroma, Schwannoma, Hearing Loss, and Tissue Biopsy.

Ronna Hertzano is an Otolaryngologist in Baltimore, Maryland. Dr. Hertzano is highly rated in 8 conditions, according to our data. Her top areas of expertise are Hearing Loss, Occupational Hearing Loss, Tinnitus, and Ruptured Eardrum. Dr. Hertzano is currently accepting new patients.

Nasir Bhatti is an Otolaryngologist in Baltimore, Maryland. Dr. Bhatti is highly rated in 3 conditions, according to our data. His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Laryngeal Nerve Damage, Mastoidectomy, and Gastrostomy. Dr. Bhatti is currently accepting new patients.

Mark Schneyer is an Otolaryngologist in Owings Mills, Maryland. Dr. Schneyer is highly rated in 20 conditions, according to our data. His top areas of expertise are Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Hearing Loss.

Alexander Hillel specializes in the medical and surgical management of patients who have scar tissue blocking their larynx and/or trachea, a condition called laryngotracheal stenosis. This condition occurs in patients who have had prolonged intubation, an autoimmune disease or a rare disease called idiopathic subglottic stenosis. He also treats patients with voice and throat problems, including spasmodic dysphonia and swallowing difficulty. After he earned his medical degree from the Tulane University School of Medicine, Dr. Hillel completed his residency in otolaryngology–head and neck surgery at the Johns Hopkins University School of Medicine and a fellowship in laryngology and airway surgery at the Emory Voice Center. Dr. Hillel directs a laboratory that seeks to better understand why scar forms in the larynx and trachea. In an effort to improve treatment, he and his team investigate the relationship between the immune system, bacteria and other antigens and scar formation in the airway. He has led a number of clinical trials to improve treatment for subglottic stenosis, including the first interventional study for idiopathic subglottic stenosis. Researchers in Dr. Hillel’s lab are also testing drugs that may halt the progression of, or reverse, scar formation, and they have engineered a drug-eluting stent that is being tested to translate to patients with subglottic stenosis. He holds sponsored grants to conduct his research from the National Institutes of Health, surgical foundations and the medical device industry. In addition to clinical and research work, Dr. Hillel has a leadership role within the Department of Otolaryngology–Head and Neck Surgery, serving as the vice director of education. Dr. Hillel is highly rated in 17 conditions, according to our data. His top areas of expertise are Spasmodic Dysphonia, Subglottic Stenosis, Perichondritis, Laryngectomy, and Endoscopy.

Laryngologist Simon Best specializes in voice and airway disorders, including the comprehensive care of professional voice-users and performers. He treats patients diagnosed with recurrent respiratory papillomatosis (RRP), vocal cord paralysis, laryngeal cancer, precancerous vocal cord dysplasia, benign laryngeal lesions (polyps, cysts, nodules), and laryngeal and tracheal stenosis. He has expertise in the operative management of vocal cord disorders, including Blue Light laser surgery and office-based management of vocal cord papilloma, dysplasia and vocal cord paralysis. Dr. Best earned a medical degree from the Yale School of Medicine and completed residency training in Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. He undertook fellowship training in laryngology at Massachusetts General Hospital. Dr. Best has a particular clinical and research interest in recurrent respiratory papillomatosis and sees patients from across the country for specialized care for this disorder. He offers operative and office-based laser for papilloma, utilizing the Blue Light laser, which allows for precise excision of papilloma while preserving underlying vocal function. Dr. Best is also a pioneer in the adjuvant use of bevacizumab for RRP, helping many patients break the cycle of repeated surgeries. The Best Laboratory studies RRP and the development of novel immunotherapies to target the underlying viral infection. This research is conducted in collaboration with the head and neck cancer and cervical cancer research groups at Johns Hopkins, which also study human papillomavirus-related diseases. In addition, Johns Hopkins is a site for ongoing clinical trials in DNA immunotherapy, the goal of which is to eliminate the causative viral infection that leads to RRP. Dr. Best is highly rated in 14 conditions, according to our data. His top areas of expertise are Laryngeal Nerve Damage, Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Laryngectomy, and Gastrostomy.

Nicholas Rowan is a sinus and skull base surgeon who helps patients with conditions such as deviated septum, nasal congestion, nasal obstruction, sinus pressure and chronic sinusitis, as well as complex issues like loss of smell, sinus cancers, cerebrospinal fluid (CSF) leaks and tumors that grow near the brain. He frequently performs nasal polyp surgery and endoscopic sinus procedures, using minimally invasive approaches to help patients recover quickly and breathe more easily. For tumors of the skull base or brain, he works closely with neurosurgeons and cancer specialists to deliver coordinated, comprehensive care. Dr. Rowan’s research is focused on improving patients’ quality of life and long-term outcomes after sinus and skull base surgery. A major part of his work involves studying the sense of smell — not just how to restore it, but how it reflects overall health. He explores how smell loss may be an early warning sign of unhealthy aging, frailty or cognitive decline. Through this work, he aims to better understand the biological link between the nose and brain, and what it can reveal about a person’s health trajectory. He works closely with biomedical engineers to develop novel diagnostic and therapeutic technologies, and he is the principal investigator of multiple ongoing clinical trials that are testing new treatments for chronic sinusitis and nasal polyps. A frequent speaker at national and international conferences, Dr. Rowan shares insights from his innovative research and surgical experience. He leads courses and delivers lectures on advanced sinus and skull base techniques, smell loss and the evolving science behind how nasal health connects to overall well-being. Dr. Rowan is highly rated in 13 conditions, according to our data. His top areas of expertise are Sinusitis, Anosmia, Pituitary Tumor, Endoscopy, and Septoplasty.

Dr. Masaru Ishii graduated from University of Pennsylvania Perelman School of Medicine. His clinical specialties include surgical management of nasal airway obstruction, chronic sinusitis and sinonasal tumors, as well as endoscopic surgery for skull base tumors. Dr. Ishii is highly rated in 12 conditions, according to our data. His top areas of expertise are Cerebrospinal Fluid Leak, Prolactinoma, Olfactory Neuroblastoma, Septoplasty, and Endoscopic Transnasal Transsphenoidal Surgery.

Dr. Matthew Stewart specializes in surgery of the inner ear, skull-base tumors, sudden hearing loss, surgical restoration of hearing through cochlear implantation, stapes surgery for otosclerosis and Bone Anchored Hearing Aid (BAHA). His research focuses on auditory processing in BAHA and health care quality implementation in microsystems. Dr. Stewart is highly rated in 9 conditions, according to our data. His top areas of expertise are Acoustic Neuroma, Schwannoma, Infant Hearing Loss, DFNB1, and Myringotomy.

Jean Kim is a surgeon-scientist whose clinical and translational research area of interest is in the pathogenesis of chronic rhinosinusitis with nasal polyposis. She cares for patients with the most severe forms of chronic rhinosinusitis, including patients with sinus disease, nasal polyposis and severe asthma. She also has expertise in the management and study of patients with autoimmune disease and complex sinus disease. Dr. Kim is co-director of the Jerome L. Greene Sjögren’s Disease Center, and is lead consultant for the Johns Hopkins Vasculitis Center and the Primary Ciliary Dyskinesia Foundation Clinical and Research Center at Johns Hopkins. She has considerable experience in conducting clinical trials in sinus and autoimmune diseases. With an active basic and translational research laboratory that studies the underlying mechanisms of airway epithelial dysfunction in sinus disease, Dr. Kim’s work is nationally and internationally recognized in the field of epithelial cell biology and allergic immune responses. She has held sponsored grants from the National Institutes of Health, various foundations and pharmaceutical companies to conduct her clinical, basic and translational research. Additionally, Dr Kim is interested in researching the pathogenesis of climate factors contributing to nonallergic rhinitis. Dr. Kim earned her medical and doctoral degrees from the University of Pittsburgh, and she completed her residency and fellowship training at the Johns Hopkins University School of Medicine. She is a member of the editorial board of the International Forum of Allergy and Rhinology, the nationally #1 ranked rhinology journal. Dr. Kim has served as a study section reviewer for the Medical Research Council of the United Kingdom, the Flight Attendant Medical Research Institute foundation and the Johns Hopkins Institute for Clinical and Translational Research, and she has received Johns Hopkins University School of Medicine Clinician Scientist Career Development Awards. Dr. Kim is highly rated in 9 conditions, according to our data. Her top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Nasal Polyps, and Sialadenitis.

Dr. Andrew Lane is the Director of the Johns Hopkins Sinus Center and performs the full range of endoscopic sinus procedures, including transnasal skull base and orbital surgeries. He is dedicated to providing cutting-edge care to his patients and developing new therapies for chronic rhinosinusitis through his clinical and basic science research. He is the longest practicing sinus specialist with advanced fellowship training in the Baltimore/Washington region, with two decades of experience in the medical and surgical management of challenging sinus disease. Dr. Lane received a bachelor's degree from Harvard University and an M.D. from the University of Pennsylvania School of Medicine. He completed his internship in general surgery and residency in Otolaryngology-Head and Neck Surgery at the University of North Carolina at Chapel Hill. He came to Johns Hopkins in 2001, after completing a fellowship in advanced endoscopic sinus surgery techniques at the University of Pennsylvania. Dr. Lane maintains a busy clinical practice while also running an NIH-funded laboratory. His research investigates the causes and potential treatments for chronic rhinosinusitis with nasal polyps, as well as how inflammation affects the sense of smell. An author of over 140 published articles and book chapters, he frequently presents his surgical and research results at national and international meetings. He has earned several prestigious awards for his research about nasal polyps and olfactory loss. Dr. Lane is Editor-in-Chief of Current Otorhinolaryngology Reports, Associate Editor of the American Journal of Rhinology and Allergy, and an Editorial Board member of the International Forum of Allergy & Rhinology. He has served on the Board of Directors of the American Rhinologic Society and chaired the Rhinology and Paranasal Sinus Committee of the American Academy of Otolaryngology – Head and Neck Surgery. He is the Rhinology section leader for the Triological Society’s Best Practice committee. Dr. Lane is often invited to speak at outside medical institutions and regularly conducts media interviews about nasal and sinus issues. Dr. Lane is highly rated in 8 conditions, according to our data. His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Sinusitis, Endoscopy, and Septoplasty.

Charles C. Della Santina specializes in surgery for treatment of hearing, balance and other ear disorders including otosclerosis, cholesteatoma, conductive and sensorineural hearing loss, acoustic neuroma/vestibular schwannoma, glomus and other tumors of the temporal bone, and other problems that cause hearing loss or abnormal vestibular (inner ear balance) sensation. He is the director of the Johns Hopkins Cochlear Implant Center. He performs acoustic neuroma surgery, cochlear implantation, stapes surgery, middle ear bone reconstruction, bone-conduction hearing device implantation, other middle ear and mastoid surgeries, removal of glomus and other temporal bone tumors, surgical treatment of temporal bone cerebrospinal fluid leaks and encephaloceles, and surgery for vestibular disorders including superior canal dehiscence syndrome, Meniere’s disease, bilateral loss of vestibular sensation, gentamicin ototoxicity and other disorders. Dr. Della Santina earned a medical degree from the University of California San Francisco School of Medicine and a doctorate in biomedical engineering from the University of California, Berkeley College of Engineering. He completed residency training in otolaryngology at the Johns Hopkins University School of Medicine in 2002, and has served on the Johns Hopkins faculty since then. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. His group’s world-leading research on vestibular implantation has been published in leading journals including the New England Journal of Medicine. Dr. Della Santina's more than 140 publications also include studies of inner ear physiology and anatomy, new clinical tests of vestibular function, and the effects of cochlear implantation, superior canal dehiscence syndrome and gentamicin on the inner ear. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. Dr. Della Santina's more than 110 publications also include studies of inner ear physiology and anatomy; new clinical tests of vestibular function; and the effects of cochlear implantation, superior canal dehiscence syndrome, and gentamicin on the inner ear. Dr. Santina is highly rated in 7 conditions, according to our data. His top areas of expertise are Jones Syndrome, Infant Hearing Loss, DFNB1, and Vertigo.

Emily Boss, M.D., M.P.H., F.A.C.S. (nee Rudnick) is director of pediatric otolaryngology and a professor of otolaryngology, pediatrics, and health policy and management at the Johns Hopkins University School of Medicine and Johns Hopkins Bloomberg School of Public Health. Dr. Boss's clinical expertise includes pediatric sinus, ear, nose, neck, and throat conditions. Dr. Boss trained at the University of California Los Angeles, Virginia Commonwealth University, and Seattle Children’s Hospital. Dr. Boss is dedicated to improving health outcomes through enhanced doctor-patient communication and organizational change. She is a federally-funded clinician scientist with research focused on patient and family-centered communication, health disparities, and surgical utilization and outcomes. She is the Medical Director for Revenue Cycle Performance Improvement for Johns Hopkins Medicine and a Physician Advisor for Care Coordination and Clinical Resource Management at Johns Hopkins Hospital. An established surgeon, physician leader, and researcher, she is passionate about performance improvement in healthcare delivery. Dr. Boss is highly rated in 6 conditions, according to our data. Her top areas of expertise are Tongue Tie, Obstructive Sleep Apnea, Otitis Media with Effusion, Adenoidectomy, and Myringotomy.

Dr. Creighton is an ear and lateral skull base surgeon. Dr. Creighton graduated from the Georgia Institute of Technology with a Bachelor of Science in biomedical engineering and earned his M.D. from Emory University. He completed a general surgery internship at the Mass General Hospital and residency in otolaryngology-head and neck surgery at Harvard. Following this he completed a fellowship in neurotology and lateral skull base surgery at Johns Hopkins. His clinical practice specializes in surgical and medical management of middle ear, inner ear, skull base and facial nerve disorders. These include skull base tumors, vestibular schwannomas (acoustic neuromas), hearing loss, cholesteatoma, cochlear implantation, stapedectomy, CSF leaks and ear drum perforations. He is trained in minimally invasive and endoscopic approaches to the ear for cholesteatoma and ear drum perforations, which reduces the need for visible incisions, and performed the first in office tympanoplsty repairs at Johns Hopkins. Dr. Creighton is highly rated in 5 conditions, according to our data. His top areas of expertise are Acoustic Neuroma, Schwannoma, Infant Hearing Loss, Mastoidectomy, and Septoplasty.